Karen J. Coffman

Person

Pawcatuck, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors
- Patent number 11,312,713
- Issue date Apr 26, 2022
- Pfizer Inc.
- Michael Aaron Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolo[2,3-d]pyrimidine derivatives
- Patent number 10,966,980
- Issue date Apr 6, 2021
- Pfizer Inc.
- Michael L. Vazquez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine deriva...
- Patent number 10,039,753
- Issue date Aug 7, 2018
- Pfizer Inc.
- Karen Jean Coffman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazole compounds for the treatment of neurodegenerative disorders
- Patent number 7,951,958
- Issue date May 31, 2011
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazole compounds for the treatment of neurodegenerative disorders
- Patent number 7,795,447
- Issue date Sep 14, 2010
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazole compounds for the treatment of neurological disorders
- Patent number 7,781,435
- Issue date Aug 24, 2010
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide compounds for the treatment of neurodegenerative disorders
- Patent number 7,345,095
- Issue date Mar 18, 2008
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazole compounds for the treatment of neurodegenerative disorders
- Patent number 7,342,118
- Issue date Mar 11, 2008
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Sulfonamide compounds for the treatment of neurodegenerative disorders
- Patent number 7,163,942
- Issue date Jan 16, 2007
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Deuterated Antiviral Compounds
- Publication number 20250051246
- Publication date Feb 13, 2025
- Pfizer Inc.
- Karen Jean COFFMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS
- Publication number 20210355117
- Publication date Nov 18, 2021
- Pfizer Inc.
- Michael Aaron BRODNEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES
- Publication number 20160045508
- Publication date Feb 18, 2016
- Pfizer Inc.
- Michael L. VAZQUEZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
- Publication number 20100184737
- Publication date Jul 22, 2010
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20100168107
- Publication date Jul 1, 2010
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20080227781
- Publication date Sep 18, 2008
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
- Publication number 20070129349
- Publication date Jun 7, 2007
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazole compounds for the treatment of neurological disorders
- Publication number 20070066613
- Publication date Mar 22, 2007
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonist...
- Publication number 20050288304
- Publication date Dec 29, 2005
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Sulfonamide compounds for the treatment of neurodegenerative disorders
- Publication number 20050222254
- Publication date Oct 6, 2005
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Imidazole compounds for the treatment of neurodegenerative disorders
- Publication number 20050215610
- Publication date Sep 29, 2005
- Pfizer Inc.
- Michael A. Brodney
- C07 - ORGANIC CHEMISTRY
Information Patent Application
5HT7 Antagonists and inverse agonists
- Publication number 20040229874
- Publication date Nov 18, 2004
- Pfizer Inc.
- Gene Michael Bright
- C07 - ORGANIC CHEMISTRY

Karen J. Coffman

Person

Patents Grantslast 30 patents

Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors

Pyrrolo[2,3-d]pyrimidine derivatives

Imidazo[4,5-c]quinoline and imidazo[4,5-c][1,5]naphthyridine deriva...

Imidazole compounds for the treatment of neurodegenerative disorders

Imidazole compounds for the treatment of neurodegenerative disorders

Imidazole compounds for the treatment of neurological disorders

Sulfonamide compounds for the treatment of neurodegenerative disorders

Imidazole compounds for the treatment of neurodegenerative disorders

Sulfonamide compounds for the treatment of neurodegenerative disorders

Patents Applicationslast 30 patents

Deuterated Antiviral Compounds

NOVEL IMIDAZO[4,5-C]QUINOLINE DERIVATIVES AS LRRK2 INHIBITORS

PYRROLO[2,3-D]PYRIMIDINE DERIVATIVES

IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS

IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

IMIDAZOLE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

SULFONAMIDE COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS

Imidazole compounds for the treatment of neurological disorders

Tetrahydronaphthylpiperazines as 5HT1B antagonists, inverse agonist...

Sulfonamide compounds for the treatment of neurodegenerative disorders

Imidazole compounds for the treatment of neurodegenerative disorders

5HT7 Antagonists and inverse agonists